<DOC>
	<DOCNO>NCT00900263</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood bone marrow laboratory patient monoclonal gammopathy undetermined significance , multiple myeloma , plasmacytoma may help doctor learn change occur DNA identify biomarkers related disease . It may also help doctor predict patient respond treatment . PURPOSE : This research study look blood bone marrow sample patient monoclonal gammopathy undetermined significance , multiple myeloma , plasmacytoma .</brief_summary>
	<brief_title>S0120 , Studying Blood Bone Marrow Samples From Patients With Monoclonal Gammopathy Undetermined Significance , Multiple Myeloma , Plasmacytoma</brief_title>
	<detailed_description>OBJECTIVES : - Establish serum , cell , bone marrow tissue bank prospectively collect sample patient monoclonal gammopathy undetermined significance ( MGUS ) , asymptomatic multiple myeloma , solitary plasmacytoma , plasma cell dyscrasia . - Evaluate feasibility accrue patient disease . - Determine whether pattern gene expression cytogenetics exist allow molecular delineation MGUS subtypes . - Characterize cellular humoral immune response know tumor antigens patient . - Cryopreserve serum/T cell future evaluation . - Preliminarily identify biological correlate may relate progression symptomatic disease . OUTLINE : Patients stratify accord diagnosis ( monoclonal gammopathy undetermined significance [ MGUS ] plasma cell dyscrasias vs asymptomatic multiple myeloma v solitary plasmacytoma ) . Blood bone marrow sample collect analyzed microarray analysis , cytogenetic analysis , immunobiology study . Unused sample may store future research study . Patients follow periodically 5 year .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Paraproteinemias</mesh_term>
	<mesh_term>Monoclonal Gammopathy Undetermined Significance</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis one follow plasmaproliferative disease : Monoclonal gammopathy undetermined significance ( MGUS ) Asymptomatic multiple myeloma Solitary plasmacytoma Other plasma cell dyscrasias Disease require therapy Willing submit research sample gene expression analysis immunologic assessment PATIENT CHARACTERISTICS : Age Not specify Performance status Zubrod 02 Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No malignancy within past 2 year except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , adequately treated stage I II cancer patient currently complete remission PRIOR CONCURRENT THERAPY : Biologic therapy No prior biologic therapy disease Chemotherapy No prior chemotherapy disease Endocrine therapy No prior endocrine therapy disease Radiotherapy No prior radiotherapy disease Surgery No prior surgery disease Other Prior concurrent bisphosphonates allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>isolated plasmacytoma bone</keyword>
	<keyword>monoclonal gammopathy undetermined significance</keyword>
</DOC>